Archives: Speakers

Rebecca Lin

Healthcare Leader | Global Growth Strategist | Educator | Keynote Speaker on AI and Innovation |
Top 25 Women Leaders in Medical Devices 2023

Rebecca Lin is a distinguished healthcare leader with a proven track record in formulating growth strategies for emerging businesses to achieve global success. Her exceptional expertise has earned her recognition as one of The Top 25 Women Leaders in Medical Devices of 2023.

Currently serving as the Chief Strategy Officer at Potrero, a cutting-edge MedTech AI innovation company based in the Bay Area, Rebecca’s visionary leadership drives the company’s growth and market expansion. Her strategic guidance has been instrumental in positioning Potrero as a trailblazer in the industry.

Rebecca’s career encompasses leadership roles in both large corporations and startups, providing her with a dynamic perspective that empowers her to guide teams at different stages of growth and maturity. Her winning strategies have left a lasting impact on esteemed companies such as Johnson & Johnson, CR Bard (acquired by Becton Dickinson), and TheraNova, spanning across business development, marketing, sales, training, and clinical management.
Having operated in both US and international markets, Rebecca has cultivated a unique blend of business acumen and technical expertise. This combination enables her to effectively communicate with diverse audiences and establish key partnerships that scale businesses globally.

Beyond her corporate roles, Rebecca actively contributes to the healthcare community. She serves as an editorial board member at the Chinese Journal of Medical Instrumentation, where she helps shape the discourse in the medical device industry. Furthermore, Rebecca shares her vast knowledge and insights as a lecturer in the Master of Translational Medicine programs at UCSF and UC Berkeley, nurturing the next generation of healthcare innovators. As a keynote speaker on AI and Innovation, Rebecca inspires audiences with her commitment to advancing healthcare through innovation and strategic expertise. She continues to be a driving force in the industry, shaping the future of healthcare.

Rebecca is an alumna of Stanford Business School and holds a Masters in Marine Biology from Sun Yat-Sen University. Her publications include a chapter titled “Industry Perspectives and Commercial Opportunities of Artificial Intelligence in Medicine” in the book ARTIFICIAL INTELLIGENCE IN MEDICINE.

Amy Raymond

Amy has been a drug discovery and development professional for 25+ years, including progressive roles in clinical operations and clinical strategy. Her clinical development experience spans all therapeutic areas and all stages of the clinical development lifecycle, from natural history studies through registrational global trials, and Long-Term Follow Up and Post Marketing surveillances.

In addition to her grasp of the unique dynamics of developing novel treatments for rare and complex diseases, Amy also leverages her combination of training and experience leading the Cell and Gene Therapy Hub at Worldwide Clinical Trials. This experience includes gene therapy, cell therapy, gene-modified cell therapy, and gene editing treatments for oncology and rare disease patient communities. Her experiences in academia, biotech, and CROs confirm that meeting the needs of all stakeholders – payers, regulators, patients, families, and sites – is a critical success factor for efficient development programs.

Ahmar Zaidi

Dr. Ahmar U. Zaidi is a pediatric hematologist who spent the last several years at the Children’s Hospital of Michigan, where he helped care for over 800 patients with sickle cell disease. He currently serves as Medical Director, Clinical Development for Agios Pharmaceuticals. Along with numerous publications and clinical trial experience, he has worked tirelessly as an advocate for sickle cell disease patients, fueled by a belief that medical misinformation and disinformation steadily contribute to poor outcomes in sickle cell disease patients. He co-founded and hosts the sickle cell educational podcast, Cheat Codes; and has been an advocate for social media as a tool for patient and physician education. He currently serves as the Chair of the Hematology Anti-Racism Task Force for the American Society of Hematology and the Chair of the Board for The Sickle Cell Reproductive Health Directive.

Karim El Habashy

Leading the Hospitality efforts for Adyen in the DACH region, always with the goal of providing the best guest experience with the latest in payments technology.

Jakub Czerwiński

Hospitality expert with background in Revenue Acceleration & PMS solutions for hotels, at Adyen looking after Central European markets, helping hotels streamline their payments set-up.